Please assess the completion status of the following clinical trial:

Trial Title: Evaluate Use of Mangosteen Juice Added to Usual Care in Reducing Risk of Recurrent Atrial Fibrillation

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Candidates for this study must meet all of the following criteria:~  * Age \>18 years~ * Documented atrial fibrillation with a clinically indicated cardioversion.~ * Anticoagulation with therapeutic INR or PTT as per Mayo Clinic cardioversion guidelines.~ * Provision of written informed consent.~Exclusion Criteria:~* Subjects will be excluded if any of the following conditions apply:~  * Presence of atrial fibrillation secondary to a reversible cause such as thyrotoxicosis or alcohol use~ * Myocardial infarction within 1 month, CABG or cardiac surgery including surgical maze or AF radiofrequency ablation within the past 3 months~ * Presence of an implanted pacemaker, atrial defibrillator, or ventricular defibrillator~ * History of bleeding diathesis or coagulopathy~ * Known atrial thrombus or contra-indication to cardioversion~ * Active infection or collagen vascular disease with active inflammation~ * Current use of corticosteroids~ * Gastrointestinal (GI) or genitourinary bleed within the past six months requiring transfusion~ * Concomitant medical illness (i.e., cancer, congestive heart failure) that may preclude protocol compliance, confound data interpretation or limit life-expectancy to less than one year~ * Known allergy to juice components~ * Inability or refusal to cooperate with study procedures~ * Unsuccessful cardioversion

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- mangosteen juice (Type: ACTIVE_COMPARATOR): subjects randomized 1:1 to this arm will receive juice containing the mangosteen ingredient
- placebo juice (Type: PLACEBO_COMPARATOR): subjects randomized 1:1 to this arm will receive specially prepared juice not containing mangosteen ingredient

Based on this trial design, predict the completion outcome and termination type (if applicable).